One-two punch of cytokine storm syndrome

Academic Article

Abstract

  • © 2020 by The American Society of Hematology. In this issue of Blood, Meyer et al describe their rationale for a combinatorial approach to fighting cytokine storm syndrome (CSS) with a one-two punch of glucocorticoids and the JAK/STAT inhibitor ruxolitinib (RUX) (see figure).
  • Published In

  • Blood  Journal
  • Digital Object Identifier (doi)

    Author List

  • Cron RQ
  • Start Page

  • 645
  • End Page

  • 646
  • Volume

  • 136
  • Issue

  • 6